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Abstract
Background: This study evaluated the utility of immunization registries in identifying vaccine
refusals among children. Among refusers, we studied their socioeconomic characteristics and
health care utilization patterns.
Methods: Medical records were reviewed to validate refusal status in the immunization registries
of two health plans. Racial, education, and income characteristics of children claiming refusal were
collected based on the census tract of each child. Health care utilization was identified using both
electronic medical record and insurance claims. Within the immunization registries of two HMOs
in the study, some providers use refusal and medical contraindication interchangeably, and some
providers tend to always use "ever refusal." Therefore, we combined medical contraindication and
refusal together and treated them all as "refusal" in this study.
Results: The immunization registry, compared to chart review, had negative predictive values of
85–92% and 90–97% for 2- and 6-year olds, and positive predictive values of only 52–74% and 59–
62% to identify vaccine refusals. Refusers were more likely to reside in well-educated, higher
income areas than non-refusers. Refusers had not opted out of health care system and continued,
although less frequently for the age 2 and under group, to use services.
Conclusion:  Without enhancements to immunization registries, identifying children with
immunization refusal would be time consuming. Since communities where refusers live are well
educated, interventions should target these communities to communicate vaccine adverse events
and consequences of vaccine preventable diseases.
Background
The decision to voluntarily forgo immunization exposes
both the children whose parents refused vaccination and
others in the community to the risks of vaccine-preventa-
ble disease.[1]
Mandatory vaccination for school entry, as required in all
states, is one effective way the United States has chosen to
control vaccine preventable diseases. Although this policy
exists in all states, exemptions are still allowed. The rea-
sons for parents to refuse to have their children vaccinated
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ranged from religious beliefs to, increasingly, a fear of
adverse reactions to certain vaccinations. A recent study
showed that the most common reason stated for refusal
(190 [69%] of 277) was concern that the vaccines might
cause harm.[2] Parents who refused to vaccinate their chil-
dren were significantly more likely than parents of vacci-
nated children to report low perceived vaccine safety and
efficacy, a low level of trust in the government, and low
perceived susceptibility to and severity of vaccine-prevent-
able diseases. Parents who refused specific or all vaccina-
tions for their children were significantly less likely to
report confidence in medical, public health, and govern-
ment sources for vaccine information and were more
likely to report confidence in alternative medicine profes-
sionals than parents of vaccinated children.
Health plans have the rare ability to document parental
vaccine refusal for a large number of children of all ages.
This study took advantage of two health plans' ability to
track immunization status, enrollment, and medical
encounters to examine immunization refusals.
The purpose of this study was to understand methods for
identifying refusers and, among those refusers, to describe
their social characteristics and health care utilization pat-
terns. To accomplish the first aim we sought to evaluate
the utility of HMO immunization registries in identifying
vaccine refusals. The knowledge of HMO immunization
registry completeness and the accuracy of social and med-
ical care correlates of vaccine refusals will aid in the devel-
opment of interventions to improve immunization
compliance and long-term follow-up of refusers. Specifi-
cally, the study objectives were firstly to assess levels of
agreement between automated immunization registries
and medical chart abstractions of vaccine refusals. Sec-
ondly, the study describes differences in social and eco-
nomic characteristics (at the census tract level) between
children in the age group of 2 to 6 years old who were not
vaccinated because of parental refusal and children who
were vaccinated. Thirdly, we described patterns of health
care utilization (well-child, outpatient, prescriptions, ER
and hospital visits) for children with a refusal of vaccina-
tion from birth to ages two and six.
Methods
The study protocol was approved by the institutional
review boards at the two participating sites and the Cent-
ers for Disease Control and Prevention.
Study population
The study population was composed of children aged 0
through 6 years old enrolled in two large health plans par-
ticipating in the CDC-sponsored Vaccine Safety Datalink
(VSD) Project. Children who were enrolled in HealthPart-
ners (HP) from 1997–2001 or Kaiser Permanente North-
west (NWK) from 1998–2001 were included in the study.
These two HMOs were chosen because of geographic loca-
tion and nationwide affiliation. One located on the west
coast, and the other in the Midwest. One is part of a
national HMO, and the other is a regional HMO.
HP documented immunization refusal beginning in 1997
as either "medical contraindication" or "parent/patient
refusal." NWK documented immunization refusal in its
vaccination database beginning in 1998 as either "Medi-
cal Contraindication to Immunizations" or "Patient/Par-
ent Refusal of Immunizations." Medical contraindication
indicated in the registry could be, for example, that the
child had a minor fever at time of visit, and the parent
chose not to let the child get vaccinated at that time. In
addition, some providers use refusal and medical con-
traindication interchangeably, and some providers tend
to always use "ever refusal." Therefore, we combine med-
ical contraindication and refusal together and treat them
all as "refusal" in this study.
Eligibility Criteria
The study used the VSD 2002 annual database. Children
born between 1994 and 2001 for HP and children born
between 1993 and 2001 for NWK were eligible for the
study. Henceforth, the two HMOs will be referred to as
HMO A and HMO B due to an IRB requirement that pro-
hibits identifying the specific data that came from each
HMO.
Clinics at both HMOs maintain vaccination histories in
an immunization registry module of electronic medical
records for all patients seen at clinics. Existing patients
who visit clinics have had their historical immunization
data verified and recorded. As new patients come into the
system, immunization histories are entered directly into
electronic medical record system by the provider. A copy
is made of the outside record and scanned into the system
to allow for quality assurance. The refusal information is
entered in the immunization registry at the point of serv-
ice. The VSD 2002 annual database used in this study
included immunization data from both the immuniza-
tion registry and the billing system.
Study inclusion criteria are shown in Table 1. The "Age 2
and under" group and "age 6" group were chosen based
on the inherent nature of immunization schedule. There
is an intense series of immunizations between birth and
the age of 18 months, where a number of vaccinations
must be given within the short time span of a few months.
After these initial vaccinations, no vaccinations are rou-
tinely recommended between ages 2 and 4. After age 4,
recommended immunizations could be taken within a 2-
year time span between the ages of 4 and 6. Due to the
requirement of the School Immunization Laws, a healthBMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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care provider of a 6-year old likely has the child's most up-
to-date immunization status. Therefore, this study had a
continuous enrollment criteria for the "Age 2 and under"
group, but only a point-enrollment requirement at age 6
for the "age 6" group. Since some refusals may be due to
a temporary medical condition (such as a headache), the
child may receive a vaccination at a later visit. Therefore,
some of ever-refuse children, did achieve up-to-date
immunization status at the evaluation age specified in
Table 1.
Children age 15 months and older on December 31, 2001
who were continuously enrolled (allowing 32 days gaps)
in the health plan from birth to 15 months of age were
included in the "age 2 and under" group. Children of age
equal or greater than 4 months and less than 15 months
old at 12/31/2001 who were continuously enrolled in the
health plan from birth to December 31, 2001 were also
included in the "age 2 and under" study population. Chil-
dren of age equal or more than 6 years old who enrolled
in the health plan at time of age 6 were included in the
"age 6" group. Children in the "Age 2 and under" group
were included to study health care utilization in the first
24 months, and children in the "Age 6 and under" group
were included to compare health care utilization in the
first 6 years between ever-refusers versus never-refusers.
Chart review
Chart reviews were performed on a random sample to val-
idate immunization status and refusal from immuniza-
tion information to collect information on date and type
of vaccination given, and the reason not given, if a vacci-
nation was mentioned but not given during the visit. The
sample selection mechanism is shown in Table 2. "Age 2
and under" group was chart reviewed from birth to age 2
or 12/31/2001, whichever occurred first. "Age 6" group
was chart reviewed from birth to age 6 1/2 or 12/31/2001,
whichever occurred first. The chart review scheme was
shown in Table 2. If there were sufficient subjects eligible,
we reviewed a 30% random sample in cells involving
refusers. If there were not enough eligible subjects in cells
involving refusers, we chart reviewed all available charts.
For the non-refusers, we over sampled those who were not
up-to-date within the restrictions of the budget at each
participating site (Table 2).
Chart abstraction was completed by trained reviewers
with years of experience in record abstraction. Training
consisted of approximately 4 hours of classroom review of
study objectives, vaccination information, and review of 2
sample charts. Abstractors then completed test charts to
assure uniformity of review by all abstractors.
Electronic Data collection
VSD data files were queried for study subjects who met
study inclusion criteria. These data included information
on enrollment, refusal status, vaccinations received, and
dates of vaccine receipt. VSD data files were also used to
identify outpatient, emergency department and urgent
care visits, and hospitalizations.
Variable definition
A child was classified as a refuser if he/she had a record of
a vaccine refusal either in the medical chart or in the
immunization registry. A child's immunization up-to-
date status was determined based on his immunization
Table 1: "Age 2 and under" and "Age 6" eligibility and up-to-date status criteria
Age 2 and under Group
Age by 12/31/01 Enrollment criteriaa Up-to-date status evaluated at Up-to-date status criteriab
>= 24 months old Birth to 15 months of age At age 2 4 DtaP, 3 IPV, 1 MMR, 3 Hib, 3 HBV
>= 18 and < 24 months Birth to 15 months of age at 12/31/2001 4 DtaP, 3 IPV, 1 MMR, 3 Hib, 3 HBV
>= 15 and < 18 months Birth to 15 months of age at 12/31/2001 3 DtaP, 2 IPV, 1 MMR, 3 Hib, 2 HBV
>= 6 and < 15 months Birth to 12/31/2001 at 12/31/2001 3 DtaP, 2 IPV, 2 Hib, 2 HBV
>= 4 and < 6 months Birth to 12/31/2001 at 12/31/2001 2 DtaP, 2 IPV, 2 Hib, 2 HBV
< 4 months Not eligible for "age 2 and under" sub-study
Age 6 Group
Age by 12/31/01 Enrollment criteriaa Up-to-date status evaluated at Up-to-date status criteriab
>= 6 years old Enrolled at age 6 At age 6 5 DtaP/DTP, 4 IPV/OPV, 2 MMR, 3 Hib, 3 HBV
< 6 years old Not eligible for "age 6" sub-study
aAllows 32 days gaps at the beginning, at the end and in-between.
bDtaP: Diphtheria, tetanus, and pertussis vaccine; IPV: Inactivated Polio Vaccine; MMR: Measles, Mumps & Rubella Vaccine;
Hib: Haemophilus influenzae type b; HBV: Hepatitis B VirusBMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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data gathered from immunization registry and supple-
mented by the medical record according to criteria in
Table 1.
In order to avoid alienating patients by collecting poten-
tially sensitive information,[3] the participating HMOs as
well as most providers throughout country, do not rou-
tinely collect demographic variables of children or their
parents. The study, therefore, identified the census block
group in which each participant lived by geocoding his/
her residential address as of December, 2001. [4-24] The
census block group was defined as a child's "community."
For each child, the study collected census information on
race (white/non-white), proportion of individuals older
than 25 years of age, educational status, and household
income. In accordance with the census definition, a child
was below poverty level if his/her total household income
was less than the poverty threshold specified for the appli-
cable family size, age of householder, and number of
related children under 18.[25]
We identified four conditions that were likely to occur fre-
quently and lead to higher medical care utilization: otitis
media and other ear disorders (ICD-9 diagnosis codes =
381, 382, 388); respiratory, including Asthma (493, 786,
466); skin, including Dermatitis (691, 692); seizure (345,
780.3) diagnoses.[26]
Outpatient visits included both regular and urgent care
visits: well child visit (ICD-9 diagnosis codes of V20 and
V70), illness visit (000–799), and injury visit (800–999).
Well child visits were defined as outpatient visits with
ICD-9 diagnosis codes of V20 and V70. Only non-birth
hospital stays were counted toward inpatient visits. Drug
prescriptions studied were antibiotics, asthma, and sei-
zure medications, which were commonly prescribed to
infants and children.
Analysis
The study collected refusal information found in the med-
ical record and in the HMO immunization registry of our
chart review sample. If the child had any type of refusal
(either parent refusal or medical contraindication) during
the study period for any vaccine they were marked as hav-
ing a refusal.
Univariate statistical comparisons were made with chi-
square test for categorical variables and t-tests for contin-
uous variables. The study used logistic regressions, Pois-
son regression models and general linear models to
estimate adjusted odds ratios as follows: we compared
ever/never use of well-child care, outpatient, emergency
room and inpatient care, and select prescriptions between
refusers and non-refusers (both up-to date and not up-to-
date for immunization), employing logistic regressions
that controlled for HMO site, patient's gender, immuniza-
tion up-to-date status, high use medical conditions, Med-
icaid status in 2001, and the child's community race/SES
variables. Differences in quantitative community charac-
teristics and rates of health care utilization were assessed
using Poisson regression models and general linear mod-
els with or without log transformations that adjusted for
the same set of variables.
Table 2: Study population
Age 2 and under Group
HMO A HMO B
# Eligible # Chart reviewed # Eligible # Chart reviewed
UTDa/Ever Refuse 19 15 (78.9%) 255 74 (29.0%)
UTD/Never Refuse 10,446 100 (1%) 18,335 71 (0.4%)
Not UTD/Ever Refuse 77 68 (88.3%) 202 66(32.7%)
Not UTD/Never Refuse 3,715 342 (9.2%) 6,097 104 (1.7%)
Total 14,257 525 (3.68%) 24,889 315 (1.27%)
Age 6 Group
HMO A HMO B
UTD/Ever Refuse 8 8 (100%) 31 28 (90.3%)
UTD/Never Refuse 3,128 30 (0.96%) 7,789 63 (0.8%)
Not UTD/Ever Refuse 25 24 (96%) 34 31 (91.2%)
Not UTD/Never Refuse 1,960 153 (7.8%) 5,305 72 (1.4%)
Total 5,121 215 (4.20%) 13,159 194 (1.47%)
aUTD: Up-to-date immunization statusBMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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Results and discussion
There are total of 14,257 children from HMO A and
24,889 children aged 2 years old or younger from HMO
B, and 5,121 children from HMO A and 13,159 children
aged 6 from HMO B who were eligible for the study. A
total 830 children aged 2 years old and under and 409
children aged 6 were selected for chart review.
Negative predictive values of electronic data compared to
chart review on immunization refusal status were 92%
and 90% for 2 years old and under and 6-year olds for
HMO A, and 85% and 97% for HMO B, respectively. Pos-
itive predictive values were only 52% and 62% for HMO
A and 74% and 59% for HMO B, using a definition of ever
refusal (any refusal for any vaccination) (Table 3). Only
between 52% and 74% of refusals documented in the
immunization registry were confirmed by text in the elec-
tronic medical record. Due to poor positive predictive val-
ues, this study cannot provide a population estimate of
the proportion of children with immunization refusal in
the study population. Closer review of the 21 cases from
the 6-year old sample with a refusal in both chart review
and HMO immunization registry revealed multiple mis-
matches with respect to date of refusal and vaccine
refused.
Since the agreement between HMO immunization regis-
try and chart reviews on immunization refusal status was
poor the following analyses were restricted to the chart
review sample only (n = 1,249, Table 2).
Table 4 shows socio-economic characteristics of refuser
and non-refuser communities, adjusting for up-to-date
immunization status, HMO site, gender, Medicaid status,
and select high use medical conditions. Compared to
communities where non-refusers lived, refusers' commu-
nities had higher average household incomes for both age
2 and under (P-value = 0.04) and age 6 (P-value = 0.03)
chart review samples. In the age 6 chart review sample,
there were fewer households below the poverty income
level (P-value = 0.04) and fewer adults without college
degree (P-value = 0.01) among refusers' communities.
Only one of 236 (0.4%) refusers in the age 2 and under
group had never been seen in an outpatient setting. Four
(1.7%) refusers in the age 2 and under group and eight
(8.7%) refusers in the age 6 group had no well-child visit.
Since enrollment criteria for the age 6 group required only
that a child was enrolled at a participating HMO at age 6,
a child in the age 6 group may have been seen at an out-
patient clinic or had a well-child visit when he/she was
not enrolled at a participating HMO.
Table 5 shows adjusted odds ratios of ever taking antibiot-
ics, asthma, or seizure medications, being admitted to a
hospital, or visiting an emergency room between refusers
and non-refusers. Covariates included were up-to date
immunization status, HMO site, gender, Medicaid status,
and select high use medical conditions. The majority of
age-6 group children took antibiotics, asthma, or seizure
medications. Compared with non-refusers, a higher per-
centage of refusers took antibiotics, asthma, or seizure
Table 3: Agreement between chart review and HMO immunization registry on ever refusal status
Agreement %
(95% CI)
HMO A
Two years old and under
n = 525
Six years old
n = 215
Sensitivity 58.5% (47.1%, 69.2%) 52.5% (36.3%, 68.2%)
Specificity 89.8% (86.6%, 92.4%) 92.6% (87.4%, 95.8%)
Positive predictive value 51.6% (41.1%, 62.0%) 61.8%#(43.6%, 77.3%)
Negative Predict value 92.1% (89.1%, 94.4%) 89.5% (83.9%, 93.4%)
Kappa 45.9% (35.8%, 56.0%) 47.8% (32.4%, 63.3%)
HMO B
Two years old and under n = 315 Six years old n = 194
Sensitivity 79.8% (71.7%, 86.2%) 89.7%#(74.8%, 96.7%)
Specificity 80.1% (73.5%, 85.5%) 84.5% (77.6%, 89.6%)
Positive predictive value 73.6% (65.3%, 80.5%) 59.3%#(45.8%, 71.7%)
Negative Predict value 85.1% (78.8%, 89.9%) 97.0%#(92.1%, 99.1%)
Kappa 59.2% (50.2%, 68.2%) 62.3% (50.0%, 74.6%)
# P-value < .05BMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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Table 4: Demographic characteristics of children communities of the chart review sample
Adjusteda Odds Ratio of Ever Refuse vs. Never Refuse Age 2 and under Group Age 6 Group
% of Pop. with Income < Poverty Levelb 0.91
(0.80, 1.04)
0.80
(0.64, 0.99)#
% of Pop. with age >= 25 yrs and < 9 yrs of Educationb 0.87
(0.74, 1.005)
0.69
(0.51, 0.92)#
Non-white% > white% versus White% > Non-white%c 1.02
(0.51, 2.02)
0.262
(0.06, 1.15)
Adjusted Mean Difference of Ever Refuse vs. Never Refuse
Average household incomed 2,820
(156, 5,485)#
4,439
(469, 8,409)#
a Adjusted for HMO, up-to-date immunization status, gender, Medicaid status, and select high use medical conditions.
b General linear model with log transformation was used.
cLogistic regression model was used.
d General linear model without log transformation was used.
# P-value < .05
Table 5: Adjusteda odds ratios of health care utilization of children in the chart review sample
Age 2 and under Group Age 6 Group
Ever Refuse vs.
Never Refuse
Other significante variables Ever Refuse vs.
Never Refuse
Other significante varia-
bles
Any prescription use of select 
medsb
0.82 (0.47, 1.43) HMO A, Up-to-date, With ear 
disorders or respiratory diagnoses.
**
Any Inpatient Useb 0.73 (0.44, 1.20) HMO A, With respiratory, skin 
disorder, or seizure diagnoses.
0.80 (0.40, 1.58) HMO A, With ear disorder 
or seizure diagnoses.
Any ER Useb 0.81 (0.56, 1.15) HMO A, Medicaid, With ear 
disorder, respiratory, skin disorder, 
or seizure diagnoses.
0.99 (0.59, 1.68) HMO A, Males, With ear 
disorder or respiratory 
diagnoses.
Total # of prescription use of 
specified med per person per 
enrollment dayd
0.93 (0.80, 1.08) Living in a white majority community, 
Up-to-date, With ear disorder, 
respiratory, skin disorder, or seizure 
diagnoses.
0.96 (0.67, 1.40) With ear disorder or 
respiratory diagnoses.
Total # of ER use per person 
per enrollment dayd
0.80 (0.64, 0.997)# HMO B, Males, Living in a non-white 
majority community, With ear 
disorder, respiratory, skin disorder, 
or seizure diagnoses.
1.13 (0.77, 1.66) HMO B, Not up-to-date, 
With ear disorder diagnoses.
Total # of inpatient days per 
personc
0.22 (0.09, 0.53)# HMO B, Not up-to-date, Without ear 
disorder diagnosis, With respiratory, 
skin disorder, and seizure diagnoses.
0.9670 (0.26, 3.54) With respiratory or seizure 
diagnoses.
Total # of outpatient visits per 
person per enrollment dayd
0.88 (0.79, 0.98)# Living in a white majority community, 
With ear disorder, respiratory, skin 
disorder, or seizure diagnoses.
0.97 (0.66, 1.41) With ear disorder or 
respiratory diagnoses.
Total # of well-child visits per 
person per enrollment dayd
1.05 (0.98, 1.12) HMO A, Without ear disorder 
diagnoses.
0.97 (0.70, 1.35) HMO A
aadjusted for HMO, up-to-date immunization status, gender, Medicaid status, and select high use medical conditions.
bLogistic regression model was used.
cPoisson regression models with log transformation was used.
d General linear model with log transformation was used.
e P-value < 0.05.
*Due to majority of age-6 group children took antibiotics, asthma, or seizure medications, no adjusted odds ratios were calculated. 86 (93.48%) of 
92 ever-refusers in the age 6 group versus 282 (77.90%) of 362 never-refusers took antibiotics, asthma, or seizure medications.
# P-value < .05BMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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medications in the age 6 group (93.48% versus 77.90%,
P-value = 0.0003).
Table 5 also compared length of hospitalization, fre-
quency of antibiotics, asthma, or seizure prescriptions,
outpatients, well-child and emergency room visits
between refusers and non-refusers, controlling for up-to
date immunization status, HMO site, gender, Medicaid
status, and select high use medical conditions. Although
in the age 6 group, refusers and non-refusers were similar,
refusers in the age 2 and under group had fewer hospital
days per person (P-value = 0.0006), were less frequently
seen in outpatient settings (P-value = 0.02) or emergency
rooms (P-value = 0.047) than non-refusers.
Conclusion
Our results indicate that there is poor agreement between
refusal status in charts and immunization registries. Poli-
cies aimed at educating refusers would be well-served by
improvement in immunization registries. Immunization
registries possibly may be improved by adding a pull-
down field that requires providers to specify a reason for
refusal (for example, minor physical illness, major physi-
cal illness, allergy, parental refusal, etc). The alternative,
tracking children through medical records would be both
expensive and time consuming for busy pediatric clinics.
Refusers are more likely to come from well-educated and
higher income areas than non- refusers. It should be
stressed that this paper makes inference about the socio-
economic make-up of the communities, not the specific
children themselves. Refusers were found not to have
opted out of the health care system and continue,
although less frequently for the age 2 and under group, to
use services in the health plans. Refusers in the age 2 and
under group had fewer hospital days per person, and had
fewer outpatient and emergency room visits than non-
refusers. The trend toward higher levels of antibiotic use
in older refusal children is consistent with higher rates of
illness observed in previous epidemiological stud-
ies.[27,28]
A previous study found that the consequences of not
being immunized can be serious. One retrospective study
investigated a cohort of 3 to 18 year old Colorado school
children from 1987–1998[1] to see if individuals and
communities experienced adverse events from personal
exemption to immunization. The study found that chil-
dren with personal (non-medical) exemptions to vaccines
were 22 times more likely to be infected with measles and
5.9 times more likely to be infected with pertussis. They
also found that unvaccinated children in day care, who
already have an increased susceptibility to disease, are up
to 60 times more likely to acquire the disease than their
vaccinated peers. It found that refusers seem to be able to
transmit disease to vaccinated individuals when the two
groups are mixed in a school or during an outbreak. Sim-
ilarly, another study that looked comprehensively at the
health consequences of religious and philosophical
exemption from immunization laws[29] in a cohort of 5–
19 year olds nation-wide from 1985–1992 found that
refusers were 35 times more likely than vaccinated indi-
viduals to contract measles from 1985–1992 in the
United States. A third study analyzed the relationship
between state-level rates of nonmedical exemptions at
school entry and pertussis incidence data for individuals
aged 18 years or younger.[30] They found that an
increased pertussis incidence was associated with an easier
granting of exemptions (incidence rate ratio = 1.53; 95%
confidence interval, 1.10–2.14) and the availability of
personal belief exemptions (incidence rate ratio = 1.48;
95% confidence interval, 1.03–2.13). The decision to
refuse immunization must carefully balance individual
rights and social responsibility. If a large enough number
people decide to forgo immunizations it runs the risk of
seeing a resurgence of vaccine preventable diseases, espe-
cially measles.[1,2] Numerous reports confirm the proba-
bility of outbreaks starting in unvaccinated individuals
and then spreading to children whose vaccination may
have failed.[1]
Because of the important public health implications
involved, it is important to understand characteristics of
children who refused to be immunized. Our results show
that refusers had not opted out of health care system but
continued to participate in it. There are opportunities at
regular clinic visits to provide information to refusers to
influence vaccine attitudes. Our findings suggest that
interventions may be implemented at clinics to improve
immunization compliance and long-term follow-up with
this subgroup of children. Since parents of refusers are
from well educated communities, interventions should
target these communities to communicate the most up-to-
date research on vaccine adverse events and the conse-
quences of vaccine preventable diseases.[31] While the
parents may not permit all routine immunizations, some
may be given. Progress may be made if the parents are
given a wide amount of information about vaccinations
including: which diseases are not affected by herd immu-
nity, more information about the diseases, another view-
point about vaccine side effects, and information that all
vaccines routinely given to children, except some influ-
enza vaccines, are thimerosol free. [32-36]
Our study has several limitations. Use of geocoding to
assign the race, education, and household income level of
the child provides information about the communities in
which the child lives, and may result in misclassification
of the specific child. However, census-based data on
income and education at the block group, tract, and ZIPBMC Pediatrics 2009, 9:18 http://www.biomedcentral.com/1471-2431/9/18
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code level have been widely used as proxies for the SES of
individuals in studies of health outcomes and health
funds allocation[4-20,22-24]. Census-based SES data at
the block group and tract level have also been used to
characterize community socioeconomic conditions [17-
20]. We have based our interpretation of the results on the
characteristics of communities in which children live. Due
to the possibility of misclassification, care should be taken
when generalizing these results to the child level. Second,
due to the small total number of refusers, as well as the
fact that some providers use refusal and medical contrain-
dication interchangeably, and that some providers tend to
always use "ever refusal," we documented "refusal" as
either "contraindication" or "refusal." Vaccine refusals
include true vaccine refusals, true contraindications, as
well as deferrals for minor illnesses. Combining these
three groups is a limitation of this study, but it is unlikely
that the data requested could be accurately obtained with-
out undertaking an expensive prospective study that
includes direct observation of provider-patient interac-
tions. Third, refusers may be more likely to receive care
from alternative providers, such as naturopathic physi-
cians. Since alternative providers are not a part of the
HMO system and few health insurance policies pay for
these services, we do not have access to data on care pro-
vided by alternative providers. Fourth, due to the small
total number of refusers in the age 6 group, a continuous
enrollment was not required and "per person per day"
analysis strategy was adopted.
The present report found that refusers, have slightly lower
but similar health care utilization in the short-run except
for prescriptions in two year olds. Thus, these families
have not opted out of health care completely, and practi-
tioners will have numerous opportunities to counsel these
parents in the first two years of their children's lives,
which is consistent with AAP policy statement on vaccine
refusers.[37]
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